U.S. flag

An official website of the United States government

NM_003001.5(SDHC):c.179+1G>C AND Hereditary cancer-predisposing syndrome

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Jun 4, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000492312.8

Allele description [Variation Report for NM_003001.5(SDHC):c.179+1G>C]

NM_003001.5(SDHC):c.179+1G>C

Gene:
SDHC:succinate dehydrogenase complex subunit C [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1q23.3
Genomic location:
Preferred name:
NM_003001.5(SDHC):c.179+1G>C
HGVS:
  • NC_000001.11:g.161328498G>C
  • NG_012767.1:g.19123G>C
  • NM_001035511.3:c.179+1G>C
  • NM_001035512.3:c.77+4828G>C
  • NM_001035513.3:c.21-12096G>C
  • NM_001278172.3:c.77+4828G>C
  • NM_001407115.1:c.179+1G>C
  • NM_001407116.1:c.122+1G>C
  • NM_001407117.1:c.122+1G>C
  • NM_001407118.1:c.77+4828G>C
  • NM_001407119.1:c.68+1G>C
  • NM_001407120.1:c.68+1G>C
  • NM_001407121.1:c.122+1G>C
  • NM_003001.5:c.179+1G>CMANE SELECT
  • LRG_317t1:c.179+1G>C
  • LRG_317:g.19123G>C
  • NC_000001.10:g.161298288G>C
  • NM_003001.3:c.179+1G>C
Links:
dbSNP: rs1057517818
NCBI 1000 Genomes Browser:
rs1057517818
Molecular consequence:
  • NM_001035512.3:c.77+4828G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001035513.3:c.21-12096G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001278172.3:c.77+4828G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001407118.1:c.77+4828G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001035511.3:c.179+1G>C - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001407115.1:c.179+1G>C - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001407116.1:c.122+1G>C - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001407117.1:c.122+1G>C - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001407119.1:c.68+1G>C - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001407120.1:c.68+1G>C - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001407121.1:c.122+1G>C - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_003001.5:c.179+1G>C - splice donor variant - [Sequence Ontology: SO:0001575]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000581223Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Likely pathogenic
(Jun 4, 2024)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Ambry Genetics, SCV000581223.7

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The c.179+1G>C intronic variant results from a G to C substitution one nucleotide after coding exon 3 of the SDHC gene. This variant has been observed in at least one individual with a personal and/or family history that is consistent with SDHC-associated disease (Ambry internal data).This nucleotide position is highly conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will weaken the native splice donor site and may result in the creation or strengthening of a novel splice donor site. RNA studies have demonstrated that this alteration results in abnormal splicing in the set of samples tested (Ambry internal data). Based on the majority of available evidence to date, this variant is likely to be pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Mar 16, 2025